| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/21/2006 | CN1788719A Leucogen slow release composition and preparation process thereof |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives |
| 06/21/2006 | CN1260213C Preparation of non-crystalline at orvastatin calcium |
| 06/21/2006 | CN1259972C Anticoagulant agent and humanized anti-von willebrand factor monoclonal antibody |
| 06/21/2006 | CN1259925C Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 06/21/2006 | CN1259918C Use of bile acid or bile salt fatty acid conjugates |
| 06/21/2006 | CN1259908C Hydrolysis-optimized liplid emulsions and use thereof |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064147 Amino acids with affinity for the α-2-delta-protein |
| 06/20/2006 | US7064107 Prevention and reduction of blood loss |
| 06/20/2006 | US7063845 Human anti-CD40 antibodies |
| 06/20/2006 | CA2379633C Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/15/2006 | WO2006062249A1 Substituted heterocyclic compound and thrombopoietin receptor activator |
| 06/15/2006 | WO2006062247A1 Substituted heterocyclic compound and thrombopoietin receptor activator |
| 06/15/2006 | WO2006062240A1 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
| 06/15/2006 | WO2006061685A1 A cost-effective process for preparation of manufacture of iron sucrose |
| 06/15/2006 | WO2006061336A2 Oral compositions for absorption of phosphorus compounds |
| 06/15/2006 | WO2006061199A1 Use of staurosporine derivatives for the treatment of multiple myeloma |
| 06/15/2006 | WO2006061116A1 Pyrazine dicarboxamides and the use thereof |
| 06/15/2006 | WO2006042479A9 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 06/15/2006 | WO2006037449A3 Iron complex for use in the treatment and/or prevention of nutritional disorders |
| 06/15/2006 | WO2006034822A8 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 06/15/2006 | US20060130169 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls. |
| 06/15/2006 | US20060130168 Using transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem cells |
| 06/15/2006 | US20060130167 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060130166 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060128947 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128757 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 06/15/2006 | US20060128749 Compounds |
| 06/15/2006 | US20060128745 Chemical compounds |
| 06/15/2006 | US20060128740 Tricyclic androgen receptor modulator compounds and methods |
| 06/15/2006 | US20060128737 Androgen receptor agonists |
| 06/15/2006 | US20060128716 Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes |
| 06/15/2006 | US20060128685 Pyrazole derivative |
| 06/15/2006 | US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 06/15/2006 | US20060128656 Charged phospholipid compositions and methods for their use |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128624 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060128606 Fibrils |
| 06/15/2006 | US20060128013 Directed differentiation of embryonic cells |
| 06/15/2006 | US20060127874 Separating plasma from whole blood obtained from human or animal, reducing leukocytes in plasma by filtering through leukocyte reducing filter, filtering leukocyte-reduced plasma through first and second virus removal membranes in series having decreasing pore diameters, where plasma has not been frozen |
| 06/15/2006 | US20060127508 Preparation for the relief of disease |
| 06/15/2006 | US20060127507 comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; treating neutropenia and aplastic anemia |
| 06/15/2006 | US20060127460 Trombin-carrying bioabsorbable synthetic nonwoven fabric |
| 06/15/2006 | US20060127445 Anti-angiogenic compositions and methods of use |
| 06/15/2006 | US20060127440 Drug delivery systems for the prevention and treatment of vascular diseases |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127389 Fused protein with the function of both hemolysis and anticoagulation and use of it |
| 06/15/2006 | US20060127353 Fat-binding polymers |
| 06/15/2006 | CA2594102A1 Pyrazine dicarboxamides and the use thereof |
| 06/15/2006 | CA2589202A1 Use of staurosporine derivatives for the treatment of multiple myeloma |
| 06/15/2006 | CA2588979A1 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
| 06/14/2006 | EP1669462A1 Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product |
| 06/14/2006 | EP1669352A1 Thiazoline derivative and use of the same |
| 06/14/2006 | EP1669092A1 Preparation for the prophylaxis of restenose |
| 06/14/2006 | EP1668021A2 Novel thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics |
| 06/14/2006 | EP1668002A2 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 06/14/2006 | EP1667970A1 Heterocyclic- or aryloxy, -thio 0r -amino substituted indoles-2-carboxylic acids or esters as pai-1 inhibitors |
| 06/14/2006 | EP1667969A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 06/14/2006 | EP1667710A2 Means and methods for the recruitment and identification of stem cells |
| 06/14/2006 | EP1667676A1 4-(1-benzofuran-3-yl-methylideneaminoxy-propoxy)-benzoic acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairement of the fibrinolytic system and of thrombisis |
| 06/14/2006 | EP1667670A1 4-(1h-indol-3-yl-methylideneaminoxy-propoxy)-benzoic acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairement of the fibrinolytic system and of thrombisis |
| 06/14/2006 | EP1667641A1 Cosmetic or dermatological preparations having a content of isoflavones and licochalcone a |
| 06/14/2006 | EP1496884B1 Association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1341819B1 Use of fibrin/fibrinogen peptides and proteins for the manufacture of a medicament |
| 06/14/2006 | EP1341770B1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/14/2006 | EP1261361B1 Oral, nasal and pulmonary dosage formulations of copolymer 1 (glatiramer acetate) |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1173186B1 Use of tagatose to enhance key blood factors |
| 06/14/2006 | EP0966283B1 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells |
| 06/14/2006 | DE19941897B4 IL-6 Rezeptor-Protein, Beta-Kette (gp130) des IL-6 Rezeptor-Proteins, für diese Proteine kodierende DNA, davon abgeleitete RNA, Peptid mit den Aminosäuren 771-811 dieser Beta-Kette oder Teilen davon und deren Verwendungen IL-6 receptor protein beta-chain (gp130) of the IL-6 receptor protein, DNA encoding for these proteins, derived RNA, peptide with the amino acids 771-811 of the beta-chain or parts thereof and their uses |
| 06/14/2006 | DE102004059219A1 Pyrazindicarbonsäureamide und ihre Verwendung Pyrazindicarbonsäureamide and their use |
| 06/14/2006 | CN1787840A Drug for treating hemophilia and method of treating hemophilia using the same |
| 06/14/2006 | CN1786032A Erythrogenin/immune globulin Fc fusion protein, its sypthesis method and application |
| 06/14/2006 | CN1785383A Medicinal preparation for treating embolus and its preparation method |
| 06/14/2006 | CN1785380A Quality control method of Chinese medicinal preparation |
| 06/14/2006 | CN1785367A Medicine for trenting flooding and spotting, haematemesis and homafecia |
| 06/14/2006 | CN1785366A Gastric blood paste suppressing agent and its preparation method |
| 06/14/2006 | CN1785344A Jinkui kidney qi fnst dispersion solid preparation and its preparation method |
| 06/14/2006 | CN1785313A Medicinal preparation for heart brain healting and its preparation method |
| 06/14/2006 | CN1785279A Blood supplementing iron supplementing medicineal preparation and its preparation method |
| 06/14/2006 | CN1785270A Chinese medicine used for increasing leucocyle, treating thrombocytopenia anl its preparation method |
| 06/14/2006 | CN1785260A Chinese medicine for treating vacuity detriment |
| 06/14/2006 | CN1785237A Duyiwei dripping pill prepn. and its preparing method |
| 06/14/2006 | CN1785220A Method for quality control of blood-bonifying Chinese angelica prepn. |
| 06/14/2006 | CN1785216A Medicinal composition contg. total ginkgo flavone, its prepn. method and use |
| 06/14/2006 | CN1785210A Melthod for preparing synthetic blood |
| 06/14/2006 | CN1785172A Transfusion contg. tanshinone II A sodium sulfonate and its prepn. method |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/14/2006 | CN1259064C Hemostatic |
| 06/14/2006 | CN1259042C Calcium phenol sulfonate dispersive tablets and their preparation |
| 06/14/2006 | CN1259035C Chinese medicinal preparation of anti embolus disease and its preparation method |
| 06/13/2006 | US7060805 Methods for isolating tissue factor inhibitor |
| 06/13/2006 | US7060731 Such as meglumine, 3-methylamino-1,2 propandiol or 2-(methylamino)-ethanol as complement inhibitors, to combact activation of the kinin/kallikrein system or as an anticoagulant |
| 06/13/2006 | US7060707 Isoquinoline derivatives |